# Topical IL-1-Ra for Treatment of Posterior Blepharitis

> **NCT00681109** · PHASE1,PHASE2 · COMPLETED · sponsor: **Reza Dana, MD** · enrollment: 75 (actual)

## Conditions studied

- Posterior Blepharitis

## Interventions

- **DRUG:** 2.5% IL-1Ra
- **DRUG:** Placebo
- **DRUG:** 5% IL-1Ra

## Key facts

- **NCT ID:** NCT00681109
- **Lead sponsor:** Reza Dana, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681109, "Topical IL-1-Ra for Treatment of Posterior Blepharitis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00681109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*